Researchers at Stanford have developed a method of using intact genetically modified pathogens for more sensitive and accurate diagnosis of pathogenic infection.
Stanford researchers at the Camarillo Lab have developed a neural-network based model that can provide real-time calculation of brain strain based on instrumented mouthguard kinematics signals.
Researchers at Stanford have developed a distributed digital "black box" audit trail design for connected and automated vehicle data and software assurance.
The Heilshorn group has developed a platform for 3D bioprinting which stiffens the structure post-printing using chemistry that is completely bioorthogonal.
Stanford researchers are investigating a new method and possible apparatus for neurostimulation of the cochlea for restoration of hearing while minimizing damage to residual hearing.
Stanford researchers have used deep learning to create a radiotherapy treatment plan verification algorithm. Patient specific dose verification is traditionally done by checking the dose in a patient-mimicking phantom or by using an independent dose calculation algorithm.
Researchers at Stanford and the Chan Zuckerberg Biohub have discovered cross reactive, broadly neutralizing human antibodies against all serotypes of dengue virus.
Engineered cytotoxic T cells are a promising class of cell therapies. These living drugs are capable of selectively killing blood cancers, such as acute myeloid leukemia (AML), and delaying its progression.